Diagnosis and Management of Cerebral Venous Sinus Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia
Top Cited Papers
- 1 July 2021
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 52 (7), 2478-2482
- https://doi.org/10.1161/strokeaha.121.035564
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a reviewExpert Review of Hematology, 2019
- Transitioning patients with immune thrombocytopenia to second‐line therapy: Challenges and best practicesAmerican Journal of Hematology, 2018
- Cerebral venous thrombosisNature Reviews Neurology, 2017
- A Multicenter Study of 1144 Patients with Cerebral Venous Thrombosis: The VENOST StudyJournal of Stroke and Cerebrovascular Diseases, 2017
- Evaluation and Management of Cerebral Venous ThrombosisCONTINUUM: Lifelong Learning in Neurology, 2014
- Diagnosis and Management of Cerebral Venous ThrombosisStroke, 2011
- Headache as the only neurological sign of cerebral venous thrombosis: a series of 17 casesJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Headache in cerebral venous thrombosisNeurological Sciences, 2004
- Prognosis of Cerebral Vein and Dural Sinus ThrombosisStroke, 2004
- Isolated intracranial hypertension as the only sign of cerebral venous thrombosisNeurology, 1999